These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34960182)
1. Impact of Molecular Modifications on the Immunogenicity and Efficacy of Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates in Mice. Malavé CM; Lopera-Madrid J; Medina-Magües LG; Rocke TE; Osorio JE Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960182 [TBL] [Abstract][Full Text] [Related]
2. Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine. Stading B; Ellison JA; Carson WC; Satheshkumar PS; Rocke TE; Osorio JE PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005958. PubMed ID: 28976983 [TBL] [Abstract][Full Text] [Related]
3. Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis). Stading BR; Osorio JE; Velasco-Villa A; Smotherman M; Kingstad-Bakke B; Rocke TE Vaccine; 2016 Oct; 34(44):5352-5358. PubMed ID: 27650872 [TBL] [Abstract][Full Text] [Related]
4. A recombinant rabies vaccine that prevents viral shedding in rabid common vampire bats (Desmodus rotundus). Cárdenas-Canales EM; Velasco-Villa A; Ellison JA; Satheshkumar PS; Osorio JE; Rocke TE PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010699. PubMed ID: 36026522 [TBL] [Abstract][Full Text] [Related]
5. Raccoon poxvirus as a mucosal vaccine vector for domestic cats. Osorio JE; Frank RS; Moss K; Taraska T; Powell T; Stinchcomb DT J Drug Target; 2003; 11(8-10):463-70. PubMed ID: 15203914 [TBL] [Abstract][Full Text] [Related]
6. SAFETY, IMMUNOGENICITY, AND EFFICACY OF INTRAMUSCULAR AND ORAL DELIVERY OF ERA-G333 RECOMBINANT RABIES VIRUS VACCINE TO BIG BROWN BATS ( Gilbert AT; Wu X; Jackson FR; Franka R; McCracken GF; Rupprecht CE J Wildl Dis; 2020 Jul; 56(3):620-630. PubMed ID: 31895645 [TBL] [Abstract][Full Text] [Related]
8. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755 [TBL] [Abstract][Full Text] [Related]
9. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein. Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806 [TBL] [Abstract][Full Text] [Related]
10. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice. Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of recombinant rabies virus (ERAGS) in mice and raccoon dogs. Yang DK; Kim HH; Choi SS; Kim JT; Lee KB; Lee SH; Cho IS Clin Exp Vaccine Res; 2016 Jul; 5(2):159-68. PubMed ID: 27489806 [TBL] [Abstract][Full Text] [Related]